About
Based in
Investor Contact:
Managing Director
jfeffer@lifesciadvisors.com
![](https://ml.globenewswire.com/media/N2IyZjZlOWEtYjYyZS00NzZkLWJkOGEtMjI4ZDRiZTdmZGFiLTEyMTgwODg=/tiny/NeuroPace-Inc-.png)
2024 GlobeNewswire, Inc., source
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
6.5 USD | 0.00% |
|
+1.88% | -36.95% |
May. 13 | Morgan Stanley Lowers Price Target on NeuroPace to $9.50 From $13, Keeps Equalweight Rating | MT |
May. 08 | NeuroPace, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
About
Based in
Investor Contact:
Managing Director
jfeffer@lifesciadvisors.com
2024 GlobeNewswire, Inc., source
1st Jan change | Capi. | |
---|---|---|
-36.95% | 187M | |
+7.23% | 217B | |
+11.31% | 191B | |
+28.94% | 154B | |
+32.00% | 112B | |
-0.30% | 62.84B | |
+16.09% | 53.34B | |
+0.80% | 48.83B | |
+1.23% | 35.73B | |
+23.40% | 31.18B |